United Therapeutics Cash Flow Statement (2009-2026) | UTHR

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	172.60M	162.70M	112.20M	239.90M	116.00M	239.30M	132.10M	240.90M	259.20M	267.60M	217.10M	306.60M	278.10M	309.10M	301.30M	322.20M	309.50M	338.70M	364.30M	274.90M
Depreciation and Depletion (Quarter)												14.80M	18.60M	18.80M	19.40M	19.60M	20.90M	21.50M	22.70M	21.60M
Share-based Compensation (Quarter)	29.10M	-58.60M	0.20M	-21.10M	32.20M	30.90M	-30.60M	-12.40M	13.80M	21.10M	-8.70M	11.40M	0.10M	105.50M	-104.80M	15.30M	0.20M	93.20M	-92.10M	58.30M
Deferred Taxes (Quarter)																				25.90M
Asset Writedowns and Impairment (Quarter)	2.30M		-94.20M	1.70M			-5.30M
Cash from Operations (Quarter)	148.20M	185.60M	174.60M	288.70M	127.00M	258.60M	128.20M	374.80M	106.30M	346.20M	150.70M	376.50M	232.20M	377.20M	341.20M	461.20M	191.70M	562.10M	346.20M	463.30M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
Amortization of Deferred Charges (Quarter)
Depreciation & Amortization (CF) (Quarter)	12.40M	12.40M	12.60M	12.50M	12.70M	12.90M	13.20M	13.30M	12.90M	13.30M	13.70M	15.00M	18.70M	19.10M	19.70M	19.80M	21.10M	21.90M	22.80M	22.60M
Change in Working Capital
Change in Receivables (Quarter)	32.40M	39.30M	-14.10M	-28.10M	2.80M	58.30M	-11.30M	-85.90M	138.10M	-14.00M	20.30M	28.30M	-16.50M	51.10M	-62.50M	42.70M	57.30M	-81.60M	52.50M	-38.20M
Change in Inventory (Quarter)	-3.00M	8.20M	0.10M	-5.70M	4.60M	0.60M	13.90M	2.50M	1.00M	3.10M	7.00M	9.30M	14.70M	11.30M	11.60M	11.20M	7.40M	17.50M	16.50M	40.10M
Change in Account Payables (Quarter)
Change in Accured Expenses (Quarter)	27.20M	19.80M	-34.50M	-10.80M	23.90M	22.30M	9.10M	2.80M	38.00M	39.40M	-23.10M	1.90M	25.80M	33.00M	-18.00M	-2.60M	46.10M	31.20M	23.20M	-12.70M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
Investing Activities
Capital Expenditures (Quarter)	-1.80M	46.90M	70.60M	13.50M	17.00M	-16.70M	0.70M	18.40M	67.60M	-51.20M	-16.40M	23.60M	59.70M	76.50M	86.70M	74.90M	-8.70M	281.40M	-231.30M	99.60M
Change in Intangibles (Quarter)
Acquisitions (Quarter)
Change in Acquisitions & Divestments (Quarter)	-63.80M	958.40M	366.60M	131.90M	378.50M	-506.60M	1,017.70M				2,137.30M	475.30M	196.50M	160.00M		611.70M	304.20M	182.50M	485.50M	1,307.90M
Cash from Investing Activities (Quarter)	-48.90M	-235.90M	-195.80M	-359.20M	-169.00M	-94.00M	-189.30M	-221.10M	-227.20M	-313.40M	42.10M	735.30M	-80.00M	-114.90M	-123.20M	-164.70M	-299.90M	140.90M	-227.60M	743.70M
Financing Activities
Other financing activities (Quarter)	10.80M	14.00M	44.40M	4.30M	23.90M	4.70M	-27.00M	3.40M	24.70M	4.60M	-84.10M	42.20M	52.10M	32.50M	-0.10M	16.60M	18.10M	40.20M	99.00M	68.30M
Cash from Financing Activities (Quarter)	10.60M	16.60M	7.50M	-11.00M	23.90M	7.00M	55.50M	48.60M	24.70M	7.60M	-92.80M	-1068.00M	-48.00M	-64.10M	-74.70M	-93.80M	-198.60M	-956.00M	98.40M	-1484.40M
Additional items
Exchange Rate Effect (Quarter)
Change in Cash (Quarter)	109.90M	-33.70M	-13.70M	-81.50M	-18.10M	171.60M	-5.60M	202.30M	-96.20M	40.40M	100.00M	43.80M	104.20M	198.20M	143.30M	202.70M	-306.80M	-253.00M	217.00M	-277.40M
Free Cash Flow (Quarter)	150.00M	138.70M	104.00M	275.20M	110.00M	275.30M	127.50M	356.40M	38.70M	397.40M	167.10M	352.90M	172.50M	300.70M	254.50M	386.30M	200.40M	280.70M	577.50M	363.70M
Net Cash Flow (Quarter)	109.90M	-33.70M	-13.70M	-81.50M	-18.10M	171.60M	-5.60M	202.30M	-96.20M	40.40M	100.00M	43.80M	104.20M	198.20M	143.30M	202.70M	-306.80M	-253.00M	217.00M	-277.40M

Research Tools

Developers

United Therapeutics Cash Flow Statement (2009-2026) | UTHR

Research Tools

Developers

United Therapeutics Cash Flow Statement (2009-2026) | UTHR

Create an account

Sign In

Reset Password